BUSINESS4 years ago
Cara Therapeutics Inc. (NASDAQ:CARA) And Vifor Pharma Receive Priority Review For KOSUVA™’s NDA
Cara Therapeutics Inc. (NASDAQ:CARA) and Vifor Pharma have announced that the US FDA has accepted and given Priority Review for KORSUVA™’s New Drug Application (NDA). KORSUVA...